Results 1 to 10 of about 192,096 (187)
ASOG: AntiSense Oligonucleotide Generator [PDF]
Antisense oligonucleotides (ASOs) are used in both fundamental research and clinical applications to modulate gene expression by targeting the RNA transcript of specific genes.
Jonah Kimi +6 more
doaj +2 more sources
Pharmacokinetics of antisense oligonucleotide drugs [PDF]
This review covers the pharmacokinetic characteristics of the various antisense oligonucleotide drugs. A comparison of the pharmacokinetics of drugs first and second generation.
M. R. Khaitov, V. V. Smirnov
doaj +1 more source
Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics [PDF]
Antisense oligonucleotides (As-ODNs) are single stranded, synthetically prepared strands of deoxynucleotide sequences, usually 18–21 nucleotides in length, complementary to the mRNA sequence of the target gene.
Mansoor, Moizza, Melendez, Alirio J.
core +8 more sources
Antisense oligonucleotide targeting nicotinamide N-methyltransferase exhibits antitumor effects [PDF]
Nicotinamide N-methyltransferase (NNMT) is one of the methyltransferase family genes. It consumes S-adenosyl-l-methionine (SAM), which is required for DNA methylation and histone methylation for epigenetic regulation, to produce 1-methylnicotinamide from
Tomoaki Hara +13 more
doaj +2 more sources
Antisense oligonucleotides [PDF]
There are few disease-modifying therapeutics for neurodegenerative diseases, but successes on the development of antisense oligonucleotide (ASO) therapeutics for spinal muscular atrophy and Duchenne muscular dystrophy predict a robust future for ASOs in medicine.
Scoles, Daniel R. +2 more
openaire +3 more sources
Antisense oligonucleotides for neurodegeneration [PDF]
Promising clinical results for Huntington's disease give hope for other ...
Leavitt, BR, Tabrizi, SJ
openaire +3 more sources
History of Research on Antisense Oligonucleotide Analogs
In the search for novel therapeutics, antisense oligonucleotide (ASO) analogs have been a major focus of research for over 40 years. They use the antisense strategy, namely they have a nucleic acid base sequence that is complementary to a portion of a ...
Jack S. Cohen
doaj +1 more source
The increase in antibacterial resistance is a serious challenge for both the health and defence sectors and there is a need for both novel antibacterial targets and antibacterial strategies.
Layla R. Goddard +9 more
doaj +1 more source
A perspective on oligonucleotide therapy: Approaches to patient customization
It is estimated that the human genome encodes 15% of proteins that are considered to be disease-modifying. Only 2% of these proteins possess a druggable site that the approved clinical candidates target. Due to this disparity, there is an immense need to
Shikha Thakur +3 more
doaj +1 more source
Antisense oligonucleotides or oligonucleotide analogues [PDF]
The present invention relates to antisense oligonucleotides or oligonucleotide analogues adapted to target pre-mRNA which encodes GNB3s and prevent aberrant splicing events.
Lester, Douglas H.
core +6 more sources

